Search Login Register

Ganglioglioma Summary

124 relevant articles (1 outcomes, 14 trials/studies) found for this Disease

Description: Rare indolent tumors comprised of neoplastic glial and neuronal cells which occur primarily in children and young adults. Benign lesions tend to be associated with long survival unless the tumor degenerates into a histologically malignant form. They tend to occur in the optic nerve and white matter of the brain and spinal cord.

Also Known As: Ganglioglioma, Benign; Ganglioglioma, Intracranial; Ganglioglioma, Malignant; Benign Ganglioglioma; Benign Gangliogliomas Show All >>

Key Drugs and Agents for Ganglioglioma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Biological Tumor Markers (Tumor Markers) : 1 outcome in 1 result : IBA
  2. 2,6-dinitrotoluene (DNT) : 5 studies in 28 results : IBA
  3. DNA (Deoxyribonucleic Acid) : 2 studies in 4 results : IBA
  4. Synaptophysin : 1 study in 13 results : IBA
  5. Paraffin : 1 study in 5 results : IBA
  6. Messenger RNA (mRNA) : 1 study in 4 results : IBA
  7. Antigens : 1 study in 3 results : IBA
  8. Androgen Receptors (Androgen Receptor) : 1 study in 2 results : IBA
  9. Collagen : 1 study in 2 results : IBA
  10. N 30 : 1 study in 2 results : IBA
Show All >>

Diseases Related to Ganglioglioma

  1. Pinealoma (Pineoblastoma)
  2. Epilepsy (Aura)
  3. Neoplasms (Cancer)
  4. Neuroepithelial Neoplasms (Gliomatosis Cerebri)
  5. Astrocytoma (Pilocytic Astrocytoma)
Show All >>

Key Therapies for Ganglioglioma

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 6 results
  2. Ventriculoperitoneal Shunt : 2 results
  3. Ventriculostomy : 1 result
  4. Decompression : 1 result
  5. Craniotomy : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.